Lv4
770 积分 2025-07-04 加入
Evaluating fostamatinib disodium as a treatment option for immune thrombocytopenia in adult patients
25天前
已完结
A Clinician Perspective for a Personalized Approach to Management of Chronic Immune Thrombocytopenia with Targeted Therapies Alone or in Combination
25天前
已完结
Real‐World Effectiveness and Safety of Fostamatinib in Difficult‐to‐Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in France
25天前
已完结
Fostamatinib: A Review in Chronic Immune Thrombocytopenia
25天前
已完结
Fostamatinib combined with TPO‐RAs or steroids as a bridge to monotherapy or as time‐limited continuous treatment in relapsed chronic ITP: A single‐centre case series
25天前
已完结
The immune thrombocytopenia paradox: Should we be concerned about thrombosis in ITP?
25天前
已完结
Glucocorticoid resistance in immune thrombocytopenia: A therapeutic challenge or a window for precision medicine?
29天前
已完结
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
1个月前
已关闭
Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies
1个月前
已完结
Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies
1个月前
已完结
皖公网安备34019202002308
